(2009). Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up.
Chicago Style (17th ed.) CitationComparison of Two Doses of Primary Intravitreal Bevacizumab (Avastin) for Diffuse Diabetic Macular Edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month Follow-up. 2009.
MLA (8th ed.) CitationComparison of Two Doses of Primary Intravitreal Bevacizumab (Avastin) for Diffuse Diabetic Macular Edema: Results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month Follow-up. 2009.
Warning: These citations may not always be 100% accurate.